Search
Climb Bio Inc
CLYMAdd to Watchlist
12.100USD
+0.200+1.68%
Close 07-31 16:00（ET）Quotes delayed by 15 min
825.03MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
15
analysts
Strong Buy
Current Rating
21.143
Target Price
+77.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Climb Bio Inc
CLYM
15
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Climb Bio Inc's price target?
Analysts forecast that Climb Bio Inc's price target is USD 9.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 8.00.
How have Climb Bio IncCLYM's recent earnings per share performed?
The market expectation was USD -0.20, while Climb Bio IncCLYM's earnings per share (EPS) for the previous quarter was USD -0.26. EPS for the next quarter is expected at USD -0.22.
What is the analyst rating for Climb Bio Inc?
Based on the ratings of Climb Bio Inc's stock from 15 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.